Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is International Biotechnology Trust EV-to-FCF?
International Biotechnology TrustLSE:IBT -2.80%36 EV-to-FCF is 9.45 as of Jul. 31, 2026, which is 17% below its 10-year median of 11.37. GuruFocus rates LSE:IBT with a GF Score™ of 36/100. The stock has 4 warning signs investors should review. Among 345 Biotechnology companies, International Biotechnology Trust ranks better than 56.23% on this metric.
LSE:IBT'
s EV-to-FCF Range Over the Past 10 Years
Min: -35.92 Med: 11.37 Max: 306.15
Current: 9.82
During the past 13 years, the highest EV-to-FCF of International Biotechnology Trust was 306.15. The lowest was -35.92. And the median was 11.37.
LSE:IBT's EV-to-FCF is ranked better than 56.23% of 345
companies
in the Biotechnology industry
Industry Median: 14.39
vs LSE:IBT: 9.82
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
International Biotechnology Trust (LSE:IBT) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
International Biotechnology Trust's PE Ratio (TTM) for today is calculated as:
International Biotechnology Trust's share price for today is £10.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. International Biotechnology Trust's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 was £2.401.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
International Biotechnology Trust EV-to-FCF Related Terms
International Biotechnology Trust EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, International Biotechnology Trust's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
International Biotechnology Trust EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, International Biotechnology Trust's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where International Biotechnology Trust's EV-to-FCF falls into.
International Biotechnology Trust's current Enterprise Value is £359.74 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. International Biotechnology Trust's Free Cash Flow for the trailing twelve months (TTM) ended in Feb. 2026 was £38.08 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
International Biotechnology Trust (LSE:IBT) has a EV-to-FCF of 9.45 as of Jul. 31, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on International Biotechnology Trust and its competitors. This is 17% below median its historical median of 11.37. According to the industry distribution chart, International Biotechnology Trust ranks #151 out of 345 companies in the Biotechnology industry, placing it in the top 43.8%.
Is International Biotechnology Trust's EV-to-FCF too high?
International Biotechnology Trust's current EV-to-FCF of 9.45 is 17% below median its 10-year median of 11.37. The Biotechnology industry median EV-to-FCF is 14.39. International Biotechnology Trust's value of 9.45 is 34.3% below this industry median. Based on the distribution chart, International Biotechnology Trust ranks #151 out of 345 companies in the Biotechnology industry, which is above the industry midpoint. Overall, International Biotechnology Trust has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does International Biotechnology Trust's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, International Biotechnology Trust ranks #151 out of 345 companies for EV-to-FCF. This puts International Biotechnology Trust in the upper half of its industry. The industry median EV-to-FCF is 14.39. International Biotechnology Trust's value of 9.45 is 34.3% below this benchmark. While the company's 10-year median is 11.37 vs. the industry median of 14.39, International Biotechnology Trust has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 14.39, based on 345 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. International Biotechnology Trust's current EV-to-FCF of 9.45 is 34.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on International Biotechnology Trust and its competitors. For the Biotechnology industry, the median EV-to-FCF is 14.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. International Biotechnology Trust's current EV-to-FCF is 9.45, which is 17% below median its own 10-year median of 11.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is International Biotechnology Trust stock overvalued right now?
International Biotechnology Trust (LSE:IBT) has a current EV-to-FCF of 9.45. The current EV-to-FCF is 9.45, which is 17% below median its 10-year median of 11.37 and 34.3% below the Biotechnology industry median of 14.39. International Biotechnology Trust's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For International Biotechnology Trust (LSE:IBT), the current EV-to-FCF is 9.45 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments ,and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.
36GF Score
Get the complete analysis for LSE:IBT
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:IBT has been successfully added to your 
